“…AVF patency is affected by many factors, including but not limited to vessel diameter, patient age, and concomitant vascular disorders such as diabetes (10). Use of adjuvant medical therapies such as intraoperative heparin administration (11)(12), anti-platelet therapy (13)(14), topical glyceryl trinitrate injection (15), and postoperative flow monitoring (16) have been proposed as means of increasing patency rates, but not enough evidence currently exists to support their use, especially considering the costs and probable side effects, such as increased risk of bleeding.…”